Tsfg, LLC Acadia Pharmaceuticals Inc Transaction History
Tsfg, LLC
- $553 Million
- Q2 2025
A detailed history of Tsfg, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Tsfg, LLC holds 75 shares of ACAD stock, worth $1,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$1,630
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
347Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$933 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$262 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$196 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$134 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.52B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...